Eli Lilly & Co. (LLY)
1042.88
+24.01
(+2.36%)
USD |
NYSE |
May 21, 13:25
Eli Lilly Research and Development Expense (TTM) : 14.11B for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Johnson & Johnson | 14.99B |
| Merck & Co., Inc. | 21.57B |
| Pfizer Inc. | 10.52B |
| Bristol Myers Squibb Co. | 9.494B |
| Nektar Therapeutics | 122.50M |